The complete presbyopia playbook in one sitting
Registration is open for Presbyopia Management Summit 2026, live December 10! Go deeper on what you already know as a panel of presbyopia experts lead the discussion on patient selection, compare all three drop classes, and share combination care strategies. Bring your questions to the live Q&A, take a shot at $750 in raffle prizes, and earn up to 3 hours of free CE in a single afternoon!
New Content
Step-by-Step Guide to Pupil Testing with Flowchart
Learn how optometrists can approach pupil abnormalities to identify potential causes efficiently and download the diagnostic and management workflow.
An Exploration of the Future of Dry Eye Therapy
Review current and emerging therapies that have the potential to change the dry eye treatment paradigm beyond symptom management to disease modification.
2026 Retina Report
Download the free report to learn how eyecare professionals are managing retinal disease in 2026!
Topics
Beyond Monotherapy: What the APL-3007 Combination Trial Signals About the Next Phase of Complement Therapy
Assessing and Managing Retinal Tears as an Optometrist
Building Effective OD–Retina Specialist Partnerships: Referral and Co-Management Best Practices
Mild NPDR can progress faster than a “see you in a year” plan allows. Learn to spot the early signs, stage accurately, and recognize the risk factors linked to progression. You’ll also review emerging therapy data, know when to refer, and get practical guidance on documentation, co-management, and building stronger relationships with retina specialists.
OCT biomarkers may predict DME treatment response
Disorganization of the retinal inner layers and photoreceptor integrity biomarkers most consistently tied to visual outcomes and injection response in DME.
Alcon acquires Neurotech, MacTel therapy Encelto
Clocking in at $550 million, the deal expands the company’s retinal portfolio with the first and only treatment for MacTel.
Stuart Therapeutics submits IND amendment for corneal wound healing
Planned proof-of-concept study is the first expansion beyond DED indication for ST-100 (vezocolmitide), with a phase 2 trial to follow in H2 2027.
EyePoint reports variable outcomes in latest phase 3 DURAVYU wet data readout
EyesUp - Glaucoma Edition
Play along with the game EyesUp to test your knowledge of interventional glaucoma management.
Beyond Co-Management: A New Growth Model for Optometry Practices
How optometrists are expanding their patient care capabilities through office-based surgery
Step-by-Step Guide to Pupil Testing with Flowchart
Learn how optometrists can approach pupil abnormalities to identify potential causes efficiently and download the diagnostic and management workflow.
Clinical Specialties
An Exploration of the Future of Dry Eye Therapy
The Impact of Presbyopia Drops on Optical Sales
Join Drs. Schaeffer and Chima as they discuss the impact of prescribing presbyopia drops on optical sales and patient care in clinical practice.
Benchmarking Your Contact Lens KPIs: What Top-Performing Practices Are Tracking
This article outlines which contact lens KPIs to track, how your optometry practice compares to industry benchmarks, and where to adjust to increase revenue.
Beyond the Sales Rep: Understanding Who’s Who in Industry
Discover who does what inside industry and how knowing the differences can save you time, find research opportunities, address insurance issues, and more.
Careers
I Saw It on TV: DTC Pharma Marketing and the New Eyecare Patient
Utilizing AI to Increase Eyecare Practice Efficiency
Featured Writers
Become a Writer
Beyond Co-Management: A New Growth Model for Optometry Practices
How optometrists are expanding their patient care capabilities through office-based surgery
